Literature DB >> 10564550

Monocyte rescue of human T cells from apoptosis is CD40/CD154 dependent.

K Sakata1, A Sakata, L Kong, N Vela-Roch, N Talal, H Dang.   

Abstract

The induction of T-cell apoptosis is regulated in part by monocytes (CD14+ cells). Human peripheral blood monocytes inhibited the spontaneous cell death of activated T cells in vitro. The inhibition of T-cell apoptosis did not require autologous monocytes. Inhibition required direct contact with monocytes and was not due to a soluble factor. Furthermore, treatment of monocytes with actinomycin D, cycloheximide and paraformaldehyde abrogated the anti-apoptotic activity of these cells. Blocking antibody to CD40 and CD154 (CD40 ligand) decreased the ability of monocytes to aid in T-cell survival, whereas, blocking LFA-1/I-CAM-1, Fas ligand and the CD4/major histocompatibility complex class II interaction did not affect the influence of monocytes on T-cell survival. This shows that monocytes rescue of activated T cells from apoptosis is dependent upon CD40/CD154 interaction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10564550     DOI: 10.1046/j.1365-3083.1999.00629.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  3 in total

1.  CD40 antisense oligonucleotide inhibition of trinitrobenzene sulphonic acid induced rat colitis.

Authors:  D Gao; A H Wagner; S Fankhaenel; T Stojanovic; S Schweyer; S Panzner; M Hecker
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

2.  Characterizing a soluble survival signal for activated lymphocytes from CD14+ cells.

Authors:  Xiaolei Tang; David E Yocum; David DeJonghe; Kathy Nordensson
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

Review 3.  Application of liposomes in drug development--focus on gastroenterological targets.

Authors:  Jian-Xin Zhang; Kun Wang; Zheng-Fa Mao; Xin Fan; De-Li Jiang; Min Chen; Lei Cui; Kang Sun; Sheng-Chun Dang
Journal:  Int J Nanomedicine       Date:  2013-04-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.